Zhang et al. also administered exogenous thymidine, raising plasma thymidine concentrations, and observed a decrease in tumour [18F]FLT uptake, suggesting that thymidine and [18F]FLT compete as substrates for TK1. The gene discussed is TK1; the disease is neoplasm.